inhibitor of apoptosis protein inhibitors (Takeda)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameinhibitor of apoptosis protein inhibitors (Takeda)
Drug Alias Nameproline mimetics (Takeda)T-3256336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of apoptosis protein 3 inhibitorsBaculoviral IAP repeat-containing protein 3 inhibitors
TargetsInhibitor of apoptosis protein 3Baculoviral IAP repeat-containing protein 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A